ࡱ>  G\pMatheus Helias Soares Ba==P-8X@"1Calibri1Calibri1Calibri1Calibri1Arial1* MS Sans Serif1Arial1Calibri1 QSegoe UI1 QSegoe UI1Arial1 Arial1Arial1Arial1Calibri1* MS Sans Serif1Calibri1 Calibri1Calibri14Calibri1 Calibri14Calibri1>Calibri1 Calibri1 Arial1Calibri1<Calibri1Calibri1?Calibri1 Calibri1Calibri1h8Cambria1,8Calibri18Calibri18Calibri1Calibri18Calibri1Calibri"R$"#,##0;\-"R$"#,##0"R$"#,##0;[Red]\-"R$"#,##0 "R$"#,##0.00;\-"R$"#,##0.00% "R$"#,##0.00;[Red]\-"R$"#,##0.008*3_-"R$"* #,##0_-;\-"R$"* #,##0_-;_-"R$"* "-"_-;_-@_-,)'_-* #,##0_-;\-* #,##0_-;_-* "-"_-;_-@_-@,;_-"R$"* #,##0.00_-;\-"R$"* #,##0.00_-;_-"R$"* "-"??_-;_-@_-4+/_-* #,##0.00_-;\-* #,##0.00_-;_-* "-"??_-;_-@_-"R$"\ #,##0;\-"R$"\ #,##0#"R$"\ #,##0;[Red]\-"R$"\ #,##0$"R$"\ #,##0.00;\-"R$"\ #,##0.00)$"R$"\ #,##0.00;[Red]\-"R$"\ #,##0.00>9_-"R$"\ * #,##0_-;\-"R$"\ * #,##0_-;_-"R$"\ * "-"_-;_-@_-FA_-"R$"\ * #,##0.00_-;\-"R$"\ * #,##0.00_-;_-"R$"\ * "-"??_-;_-@_-61_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)0+_(* #,##0_);_(* \(#,##0\);_(* "-"??_);_(@_)000000000000000B=_("R$"* #,##0.00_);_("R$"* \(#,##0.00\);_("R$"* "-"??_);_(@_)0.0 0.0000000 0.000000 0.00000 0.0000 0.000 0.000000002-_-* #,##0.0_-;\-* #,##0.0_-;_-* "-"??_-;_-@_-.)_-* #,##0_-;\-* #,##0_-;_-* "-"??_-;_-@_-61_-* #,##0.000_-;\-* #,##0.000_-;_-* "-"??_-;_-@_-83_-* #,##0.0000_-;\-* #,##0.0000_-;_-* "-"??_-;_-@_-:5_-* #,##0.00000_-;\-* #,##0.00000_-;_-* "-"??_-;_-@_-<7_-* #,##0.000000_-;\-* #,##0.000000_-;_-* "-"??_-;_-@_-                                                           ff  `                                        )     ! P " P #  # $ a> +   Q H  Q"X  Q H  Q)X  Q"X  Q     Qx""@ @   1Q""@ @   Q""@ @   Q""@ @   Q""@ @   Q"@ @  Q""@ @  Q "@ @   x @,  x!@ @,  x@ @, (| (|@ @   Q*@ @   1Y*@ @   1Q*@ @   Q*@ @   Q*x@ @  +   a!|@@ a h@ a h  @     1Q*@ @   Q*@ @   Q*x@ @   Q*@ @   Q*@ @   Q@ @  % h@ @   Q*@ @   Q*@ @   Q@ @    +|@ @  |@ @   1Y*@ @ 3  1Q*@ @ 3 (|@ @ 3  Q*@ @ 3  Q*x@ @ 3  Q*@ @ 3  Q*@ @ 3  Q@ @ 3 +|@ @ 3 "X3  Q*@ @ 3 Q*@ @ 3 & *|@ @ 3 & |@ @ 3 |@ @ 3 & l@ @ 3 & "|@ @ 3   & , + ,     a)|@  a)|  a)|   a)| @   a)|   a)|   x"@ @ ,  x "@ @ ,  x"@ @ ,  x "@ @ , ||C T}-} 0.000000}-} 0.000000}-} 0.000000}-} 0.000000}-} 0.000000}-} 0.000000}-} 0.000000}-} 0.000000}-} 0.000000}-}  0.000000}-}  0.000000}-}  0.000000}-}  0.000000}-}  0.000000}-} 0.000000}-} 0.000000}A} 0.000000ef@_-;_(@_}A} 0.000000ef@_-;_(@_}A} 0.000000ef@_-;_(@_}A} 0.000000ef@_-;_(@_}A} 0.000000ef@_-;_(@_}A} 0.000000ef @_-;_(@_}A} 0.000000L@_-;_(@_}A} 0.000000L@_-;_(@_}A} 0.000000L@_-;_(@_}A} 0.000000L@_-;_(@_}A} 0.000000L@_-;_(@_}A} 0.000000L @_-;_(@_}A} 0.00000023@_-;_(@_}A} 0.00000023@_-;_(@_}A} 0.00000023@_-;_(@_}A} 0.00000023@_-;_(@_}A}  0.00000023@_-;_(@_}A}! 0.00000023 @_-;_(@_}A}" a0.000000@_-;_(@_}}# }0.000000@_-;_(@_   }}$ 0.000000@_-;_(@_??? ??? ??? ???}A}% }0.000000@_-;_(@_}-}& 0.000000}-}' 0.000000}A}( 0.000000@_-;_(@_}A}) 0.000000@_-;_(@_}A}* 0.000000@_-;_(@_}A}+ 0.000000@_-;_(@_}A}, 0.000000@_-;_(@_}A}- 0.000000 @_-;_(@_}}. ??v0.000000̙@_-;_(@_   }(}0  0.000000}-}/  0.000000}-}1  0.000000}A}= 0.000000@_-;_(@_}-}2 0.000000}-}3 0.000000}A}4 e0.000000@_-;_(@_}}; 0.000000@_-;_(@_   }-}< 0.000000}}> ???0.000000@_-;_(@_??? ??? ??? ???}-}I 0.000000}-}? 0.000000}-}A 0.000000}-}B 0.000000}-}C 0.000000}A}D 0.000000@_-;_(@_}A}E 0.000000?@_-;_(@_}A}F 0.00000023@_-;_(@_}-}G 0.000000}U}H 0.000000@_-;_(@_ }-}Q 0.000000}}}] 0.000000@_-;_(@_  }-}^ 0.000000}-}d 0.000000}(}e0.000000}(}f0.000000}(}g0.000000}-}h 0.000000}-}o I}0.000000}-}s 0.000000}-}t 0.000000}-}u 0.000000}(}v0.000000}(}w0.000000}A}x 0.000000@_-;_(@_}(}y0.000000}(}z0.000000}(}{0.000000}(}|0.000000}(}}0.000000}A}~ 0.000000@_-;_(@_}A} 0.000000@_-;_(@_}(}0.000000}(}0.000000}-}000}-}000}A} 000@_-;_(@_}-}000}-}000}-} 000}}}-} 000}-} 000}(}000}(}000}(}000}(}000}(}000}(}000 20% - nfase1M 20% - nfase1 ef % 20% - nfase2M" 20% - nfase2 ef % 20% - nfase3M& 20% - nfase3 ef % 20% - nfase4M* 20% - nfase4 ef % 20% - nfase5M. 20% - nfase5 ef % 20% - nfase6M2 20% - nfase6  ef % 40% - nfase1M 40% - nfase1 L % 40% - nfase2M# 40% - nfase2 L渷 % 40% - nfase3M' 40% - nfase3 L % 40% - nfase4M+ 40% - nfase4 L % 40% - nfase5M/ 40% - nfase5 L % 40% - nfase6M3 40% - nfase6  Lմ % 60% - nfase1M 60% - nfase1 23 % 60% - nfase2M$ 60% - nfase2 23ږ % 60% - nfase3M( 60% - nfase3 23כ % 60% - nfase4M, 60% - nfase4 23 % 60% - nfase5M0 60% - nfase5 23 %! 60% - nfase6M4 60% - nfase6  23 %"Bom9Bom  a% #ClculoyClculo  }% $Clula de VerificaoClula de Verificao  %????????? ???%Clula VinculadaUClula Vinculada }% &Comma 2' Currency 6 (nfase1Anfase1 O % )nfase2A!nfase2 PM % *nfase3A%nfase3 Y % +nfase4A)nfase4 d % ,nfase5A-nfase5 K % -nfase6A1nfase6  F % .EntradayEntrada ̙ ??v% /9 Hiperlink  %0 Hiperlink 28 Hiperlink 2  1 K Hiperlink Visitado  %2 Moeda3( Moeda [0] 4Neutro?Neutro  e%3Normal % 5Normal 26 Normal 2 27 Normal 2 3 8Normal 3 9Normal 4 :Normal 5 ;Notab Nota  <, Porcentagem =Ruim;Ruim  % >SadauSada  ???%????????? ????HSeparador de milhares [0]@Separador de milhares 2ATexto de AvisoC Texto de Aviso %BTexto ExplicativoI5Texto Explicativo % CTtulo3Ttulo I}% DTtulo 1ETtulo 1 I}%O ETtulo 2ETtulo 2 I}%? FTtulo 3ETtulo 3 I}%23 GTtulo 47Ttulo 4 I}% HTotalMTotal %OOI$VrgulaJ Vrgula 2XTableStyleMedium2PivotStyleLight16`w]REVISTA77!  ;ffH@bZ  <3 A@@  AICMS 20%ICMS 18% ICMS 17,5%ICMS 17%ICMS 12%ICMS 0% Convnio 162CDIGO DE BARRAS (EAN)REGISTRO ANVISAGGREMPRODUTO1CONCENTRAO(ES) FARMACOLGICA(S) E APRESENTAOPRINCPIO(S) ATIVO(S)uCAT** CATEGORIA: LIBERADO (C/ PF E PMC), LIBERADO (SOMENTE C/ PF), MONITORADO, HOSPITALARES (SOMENTE C/ PF) e OUTROS:LCCT** CLASSIFICAO: POSITIVO, NEGATIVO, NEUTRO e OUTROS PFPMC 7898582380015 1861000040019542815070000713TRAMAL.100 MG COM REV LIB PROL CT BL AL PLAS OPC X 10CLORIDRATO DE TRAMADOL C/ PF E PMCPOSITIVO 7898582380312 1861000040027542815070001303.100 MG COM REV LIB PROL CT BL AL PLAS OPC X 20 7898582380022 1861000060011542815070000613%50 MG CAP DURA CT BL AL PLAS OPC X 10 7898582380350 1861000060028542815070001103%50 MG CAP DURA CT BL AL PLAS OPC X 20 7898582380039 1861000030013542815070000913&50 MG/ML SOL INJ CT 5 AMP VD INC X 1ML 7898582380046 1861000030048542815070001013 7898582380053 1861000050014542815070000813)100 MG/ML SOL OR GOT CT FR VD AMB X 10 ML 7898582380206 1861000020026542814070000202TOPERMA5% EMPL CT ENV PE/AL X 10 LIDOCANA 7898582380237 18610000200505428140700005025% EMPL CT ENV PE/AL X 30 7898582380183 1861000010012542813120000018BELARA42 MG + 0,03 MG COM REV CT BL CALEND AL PLAS INC X 21(ACETATO DE CLORMADINONA; ETINILESTRADIOLICMS 18% (ALC)ICMS 17,5% (ALC)ICMS 17% (ALC) 7897572005440 7897572005419 7897572005426 7897572005518 7897572005433 1017102000069 1017102000026 1017102000034 1017102000042 1017102000050HETORI90 MG COM VER CT BL AL/AL X 1460 MG COM VER CT BL AL/AL X 760 MG COM VER CT BL AL/AL X 1490 MG COM VER CT BL AL/AL X 290 MG COM VER CT BL AL/AL X 7 ETORICOXIBE 7898582380329 1861000040035.100 MG COM REV LIB PROL CT BL AL PLAS OPC X 30DAMATEROR 30 CAPS DAMATERPOLIVITAMNICO E MINERAISNEGATIVO 7897572002654 1017101780011 Cdigo SAPBELARINA 7898582380268 1861000070015B2 MG + 0,02 MG COM REV CT BL CALEND AL PLAS TRANS X 24 + 4 PLACEBO Categoria RefernciaOutrosSimilarNotas:(1) Alquotas de ICMS 20% - RJ; ICMS 18% - AM, AP, BA, CE, MA, MG, PB, PE, PI, PR, RN, RS, SE, SP, TO e RJ (medicamentos da Portaria MS 1318/2002 ); ICMS 17,5% - RO; ICMS 17% - Demais Estados; ICMS 12% - Medicamentos Genricos de SP e MG. reas de Livre Comrcio  ALC -: Manaus/Tabatinga (AM), Boa Vista/Bonfim (RR), Macap/Santana (AP), Guajar-Mirim (RO), Brasilia/Epitaciolndia/ Cruzeiro do Sul (AC)+(2) Liberado  Produtos liberados dos critrios de estabelecimento ou ajuste de preo (Resoluo CMED n 5, de 9 de outubro de 2003). Apenas o Preo Fbrica encontra-se liberado, devendo o Preo Mximo ao Consumidor atender s margens previstas no art. 4 da Resoluo n 04, de 12 de maro de 2015.(3) Medicamentos em embalagens hospitalares e de uso restrito a hospitais e clnicas no podem ser comercializados pelo Preo Mximo ao Consumidor. Resoluo no. 03 de 4/5/2009. 7898582380527 1861000010063542817070001603C2 MG + 0,03 MG COM REV CT BL CALEND AL PLAS TRANS X 21 + 7 PLACEBOS'ETINILESTRADIOL;ACETATO DE CLORMADINONANCM 3006.60.00 3004.90.43 3004.90.69 3004.90.39 3004.50.90 7897337710930 1002901860011STEZZA!ACETATO DE NOMEGESTROL/ ESTRADIOL 3004.32.10 7897337710947 1002901860028 7897572001923 1017100890016527300201110312 CERAZETTE'0,075 MG COM REV CT BL AL PLAS INC X 28 DESOGESTREL<2,5 MG + 1,5 MG COM REV CT BL AL PVC CALEND X 24 + 4 PLACEBO>2,5 MG + 1,5 MG COM REV CT BL AL PVC CALEND X 72 + 12 PLACEBO 7897572006119 1017100890024527313010009603'0,075 MG COM REV CT BL AL PLAS INC X 84 7897572001411 1017101010011527302401176313NUVARING#11,7 MG/2,7 MG ANEL VAG CT SACH X 1ETONOGESTREL/ETINILESTRADIOL 7897572002494 1017101020015527303801119315MERCILON CONTIV150/20MCG 21 COM REV + 0/0MCG 2 COM REV + 0/10MCG 5 COM REV CT ENV AL X BL AL PVC X 28DESOGESTREL / ETINILESTRADIOL 7897572006102 1017101020023527316010018203V150/20MCG 21 COM REV + 0/0MCG 2 COM REV + 0/10MCG 5 COM REV CT ENV AL X BL AL PVC X 84 7897572000100 1017100680021527302101113413 MERCILON *0,15MG + 0,02MG COM CT BL AL PLAS INC X 21 7897572000025 1017100680038527316010018103,0,15 MG + 0,02 MG COM CT BL AL PLAS INC X 63450 MG/ML SOL INJ CT 5 AMP VD INC X 2ML (total 100mg)'95006925 / 950074125% CMED15% CMED14% CMED 10% CMED10% CMED20% CMED 11,11% CMEDG ;HYIICJiK LULZMM*NGOOU/W{WEX?YY/[T[Y\ccB G  /'+S[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{    # + 3 ; C K S [ c k s {                     # + 3 ; C K S [ c k s {                     # + 3 ; C K S [ c k s {                     # + 3 ; C K S [ c k s {                     # + 3 ; C K S [ c k s {                  #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #+3;CKS[cks{ #I  dMbP?_*+%,&jZ?'jZ?(~?)~?M\\brs00002\BRP00003C 4dXXA4DINU" y!? SMTJxIUPHx1o@nJV % lD V)QF 0R5nk)QMIT X222""bc@xj+Nc ݻ;"ݻ 5xәP!0~}:Hc'PlxC:,d xGl],( N[1a`ʨ&!1=tA8S*]%ӽqx HLpEbͅ>M<:Lʤ,fҝ-BʀN_{F=c0ķޜTw;L&<2.A*)aU.6(Wp֦CFJbg)oUmyS7?%=u+^}K(1'j{qrԭ·痾//~jֲf d%9gAAA!_!}Q" XX BP(? BP(?&\(U} !Q} Q} $Q} Q} I)Q} Q} IQ} Q} Q} $ Q}  Q}  Q}  Q} Q} $ QtJt;:9876543210/.-,+*)('&%$#"! ;           , ,   , ,,,,  @   ,,   ,; KLLMMNOPPPP   ?  @  A   R S S T R U V W Xa  X\  Yn  Z  [  \ [ \ [ \ [ \ [ \ [ \ [ \ [ \ [ i i ] j k j l l lb~  m  nr tgS@~  tp@ tOl9^S@t|rZ@tOl9^S@t|rZ@t"ƽ?S@tHطZ@t"ƽ?S@tHطZ@t_":"S@t37sZ@t_":"S@t37sZ@t(UI R@tX@t,9$O@tlIFU@ i i ] j c j l l lb~  m⩦  nr tV"b@ ty@e|j@ tqg'Pfb@tvwoi@tqg'Pfb@tvwoi@t$uIb@t5ϙ/Hi@t$uIb@t5ϙ/Hi@t@tfffffQ@~ t>@tfffffQ@t~NA~6|H@tKǜgP@t~NA~6|H@tKǜgP@t݆5G@~ t@tŬ!QD@tʳUQL@ i+ a, a- j c. j l l lb~  m  nr tJ%S@~  t}@ tNfֶiS@t >FZ@tNfֶiS@t >FZ@t_P|LKS@tZ@t_P|LKS@tZ@t׺.S@tuZ@t׺.S@tuZ@tD@t@tO@tm(lV@ i/ o0 i1 j2 k3 j4 l l lb~ m np tWiY@~ tq@ tY? tX@ t(\"a@~ t^@ t(\"a@ t۞ X@ tZaa@ t۞ X@ tZaa@ ty}X@~ tt@ ty}X@ tt@t @ t^ _@ t TT@ tF&\@ `5 a6 ^7 b2 c8 b4 p p pb~ q np t p p lb~ q ro t;2V@@ tި G@Z tj@t@tj@t@tB@tu@tB@tu@t@t[@t@t[@t@t^@ th:@ t5;NqB@ vB wG xSnB yL zM yR { { {d~ | }q ~@~@  ~u,ȮT@ ~K\@ ~u,ȮT@ ~K\@ ~5'TT@~ ~4@ ~5'TT@~ ~4@ ~{4oT@~ ~@\@ ~{4oT@~ ~@\@ ~&ES@ ~$Z@ ~*tP@ ~1DhrW@ vC wH xSnB yL zN yR { { {d~ | }q ~<.C@ ~_J@ ~OB@~ ~@ ~OB@~ ~@ ~@SB@ ~YӒI@ ~@SB@ ~YӒI@ ~(\bB@~ ~۳@ ~(\bB@~ ~۳@ ~ݔZ WA@ ~@.qG@ ~ɰ>@ ~Q}hE@ vD wIxSnB yL zO yR { { {d~    }q ~@~@  ~d$R@~ɐcY@~d$R@~ ~ @~ rR@~)rY@~ rR@~)rY@~ ~@~SXY@~ ~@~SXY@~g8KQ@~ ~@~u,pN@~A C U@ vE wJx@SnB yL zP yR { { {d~  |  }q ~اm{(@ ~Q0@ ~-'@~(\0@~-'@~(\0@~[R'@~āci0@~[R'@~āci0@~4!"ԗ'@~]aP0@~4!"ԗ'@~]aP0@~d@~ @~#@~82+@ vF wKxSnB yL zQ yR { { {d~  |  }q ~@~!@  ~KqD@~ ~@~KqD@~ ~@~*,D@~ ~n@~*,D@0~n@~!@~L@~!@~L@~l@~@~s8"A@~jG@ `S aT^ѶB b cU j p p lb~  q2  nr tG@ ҸOi@ t(~q@ tjh@t wq@tjh@t wq@t Kh@td /Rp@u Kh@td /Rp@uveh@tӹ p@tveh@tӹ p@ug@tp'uo@t ?d@tuk@ Q vZ w[x IB yV zW yX { {Y c   }s ~J= ByC@~  ~W@ ~{CLC@~ ~ɳ@~C@@~R hF@~nB@~6Ӂ'I@~϶j@@~^驋\F@~ ڗB@~ ~@~*SQ@@~؏F@~υ|A@~%HjG@~_kW>@~jf-ZD@ `^ a_^0 B b] c` b> p p lc~  q}  ro t;2V@@ tި G@Z tj@t@tj@t@tB@tu@tB@tu@t@t[@t@t[@t@t^@th:@t5;NqB@ `i aj ^k b< cl bm p p lb~  qȦ  ro t;2V@@ tި G@Z tj@t@tj@t@tB@tu@tB@tu@t@t[@t@t[@t@t^@th:@t5;NqB@ vt wuxm=U@]@~ @qn^@J.Z@J.Z@  v{ w| } y~  y { { {b~  |.Ц  }o*  @@@E@@E@YN=@~ ,@YN=@~ ,@y0H=@~ @y0H=@~ @8~߿<@^iC@KK8@uA@ v w  y~  y { { {b~  |ZЦ  }oB @@?@@?@@@g@@g@QQ@~ I@QQ@I@R@1@G)R@ Y@ h v w  y  y { { {b~  |Ц  }o &S[N@ G,T@ M#M@?g͏xT@M#M@?g͏xT@].;oM@XmXT@].;oM@XmXT@nSAM@Y28T@nSAM@Y28T@l ]K@._x%S@QIH@^ӃP@ v w  y  y { { {b~  |Ц  }o` Ȩ@!@.@@.@@@@@@@@@@@(\C@I?I9@eQzA@ v w  y  y { { {b~  |Ц  }o~  e@ ME]@ @@@@XT@H] \@XT@H] \@[Y9T@~ @[Y9T@~ @Ρ US@K^Z@d .ߦR@ CY@ h v w  y  y { { {b~  |Ц  }o 5v@@ X@|@ ϹҪE@~ |@ϹҪE@מY&?@~ Ұ@מY&?@$Ұ@0@@0@@464=@»\/D@>V9@#ng_A@ v w  y  y { { {b~  |Ц  }o H®U@~  j@ Ǟ='U@~ @Ǟ='U@*@m@]@m@]@T@$"\@~ T@$"\@̾@I@@LFS@4%Z@ Q* dddddddddddddddddd  dd "ddddddddddddddD4l@~D@`4. ;@!H@"@#; $,%,&,',(,),*,+,,,-,.,/, ee ffffffg. dd !f!*! dddddddddddddddddd "g"" d "ddddddddddddd #h#*# dddddddddddddddddd*$ dddddddddddddddddd*% dddddddddddddddddd*& dddddddddddddddddd*' dddddddddddddddddd*( ddddssssssssssssss*) dddssssssssssssss** ddddssssssssssssss*+ ddddssssssssssssss*, ssssssssssssssssss*- ssssssssssssssssss*. ssssssssssssssssss*/ ssssssssssssssssss$,XTTT...........,_;l(    TXPPQQ?  ]4@ =L[I~ ;<<Marinho, Raphael: A partir de Fevereiro registro ser nosso< f  ;  ThXPPQQ?d]4@ PvxHP^Lj ;<<Marinho, Raphael: A partir de Fevereiro Registro ser nosso< f  ;Marinho, Raphael  Marinho, Raphael >@UinjnA b !!""## b(b(9?ϿggD Oh+'0HPt Penhalves Iglesias, EderMatheus Helias SoaresMicrosoft Excel@kS@ ?@8 ՜.+,D՜.+, PXl t|  Grunenthal REVISTA  Planilhas `'O{   8MSIP_Label_1f22b0d6-cb08-48e4-b81e-c118f64f4880_Enabled7MSIP_Label_1f22b0d6-cb08-48e4-b81e-c118f64f4880_SiteId4MSIP_Label_1f22b0d6-cb08-48e4-b81e-c118f64f4880_Ref6MSIP_Label_1f22b0d6-cb08-48e4-b81e-c118f64f4880_SetBy8MSIP_Label_1f22b0d6-cb08-48e4-b81e-c118f64f4880_SetDate5MSIP_Label_1f22b0d6-cb08-48e4-b81e-c118f64f4880_Name<MSIP_Label_1f22b0d6-cb08-48e4-b81e-c118f64f4880_Application EMSIP_Label_1f22b0d6-cb08-48e4-b81e-c118f64f4880_Extended_MSFT_Method SensitivityTrue(1aa3f197-39d5-4269-bcea-93372aa086d9Xhttps://api.informationprotection.azure.com/api/1aa3f197-39d5-4269-bcea-93372aa086d9 Raphael.Marinho@grunenthal.com$2017-11-13T09:59:30.7622279-02:00Business Use(Microsoft Azure Information Protection AutomaticBusiness Use  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry FWorkbookSummaryInformation(DocumentSummaryInformation8